Lithium stimulates gene expression through the AP-1 transcription factor pathway

Molecular Brain Research

Volumn 58, Issue 1-2, 1998, Pages 225-230

  Yuan, Pei Xong ^a   Chen, Guang ^a   Huang, Li Dong ^a   Manji, Husseini K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AP 1; Gene expression; GSK 3; Lithium; Manic depressive; PKC

Indexed keywords

LITHIUM; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; MANIC DEPRESSIVE PSYCHOSIS; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE; SIMIAN VIRUS 40;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHLORIDES; CONSENSUS SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GLIOMA; HUMANS; LITHIUM CHLORIDE; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUROBLASTOMA; POTASSIUM CHLORIDE; PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT FUSION PROTEINS; RUBIDIUM; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIMIAN VIRUS 40; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032527821     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00114-4     Document Type: Article

References (28)

1. P. Angel, M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, M. Karin, Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor, Cell 49 (1987) 729-739.
2. C.L. Bowden, A.M. Brugger, A.C. Swann, J.R. Calabrese, P.G. Janicak, F. Petty, S.C. Dilsaver, J.M. Davis, A.J. Rush, J.G. Small, Efficacy of divalproex vs. lithium and placebo in the treatment of mania, JAMA 271 (1994) 918-924.
3. W.J. Boyle, T. Smeal, L.H. Defize, P. Angel, J.R. Woodgett, M. Karin, T. Hunter, Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity, Cell 64 (1991) 573-584.
4. G. Chen, P.X. Yuan, D.B. Hawver, W.Z. Potter, H.K. Manji, Increase in AP-1 transcription factor DNA binding activity by valproic acid, Neuropsychopharmacology 16 (1997) 238-245.
5. G. Chen, P.X. Yuan, H.K. Manji, Regulation of transcription factor DNA binding activity by mood stabilizing agents, Abstracts of the American College of Neuropsychopharmacology Annual Meeting, HI, December 1997.
6. G. Chen, P.X. Yuan, Y.M. Jiang, L.D. Huang, H.K. Manji, Lithium increases tyrosine hydroxylase levels both in vivo and in vitro, J. Neurochem. 70 (1998) 1768-1771.
7. M.M. Divish, G. Sheftel, A. Boyle, V.D. Kalasapudi, D.F. Papolos, H.M. Lachman, Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action, J. Neurosci. Res. 28 (1) (1991) 40-48.
8. F. Goodwin, K.R. Jamison, Manic-Depressive Illness, Oxford Univ. Press, New York, 1990.
9. C.M. Hedgepeth, L.J. Conrad, J. Zhang, H.C. Huang, V.M.Y. Lee, P.S. Klein, Activation of the Wnt signaling pathway: a molecular mechanism for lithium action, Dev. Biol. 185 (1997) 82-91.
10. P. Hughes, M. Dragunow, Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system, Pharmacol. Rev. 47 (1995) 133-178.
11. S.E. Hyman, E.J. Nestler, Initiation and adaptation: a paradigm for understanding psychotropic drug action, Am. J. Psychiatry 153 (1996) 151-162.
12. R.S. Jope, L. Song, AP-1 and NF-κB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium, Mol. Brain Res. 50 (1997) 171-180.
13. R.S. Jope, M.B. Williams, Lithium and brain signal transduction systems, Biochem. Pharmacol. 77 (1994) 429-441.
14. V.D. Kalasapudi, G. Sheftel, M.M. Divish, D.F. Papolos, H.M. Lachman, Lithium augments fos protoonocogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium, Brain Res. 521 (1-2) (1990) 47-54.
15. M. Karin, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem. 270 (1995) 16483-16486.
16. M. Karin, T. Smeal, Control of transcription factors by signal transduction pathways: the beginning of the end, TIBS 17 (1992) 418-422.
17. P.S. Klein, D.A. Melton, A molecular mechanism for the effect of lithium on development, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 8455-8459.
18. W. Lee, P. Mitchell, R. Tjian, Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements, Cell 49 (1987) 741-752.
19. A. Lin, T. Smeal, B. Binetruy, T. Deng, J.C. Chambard, M. Karin, Control of AP-1 activity by signal transduction cascades, Adv. Second Messenger Phosphoprotein Res. 28 (1993) 255-260.
20. H.K. Manji, R.H. Lenox, Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C, Synapse 16 (1994) 11-28.
21. H.K. Manji, W.Z. Potter, R.H. Lenox, Signal transduction pathways. Molecular targets for lithium's actions, Arch. Gen. Psychiatry 52 (1995) 531-543.
22. N. Ozaki, D.M. Chuang, Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain, J. Neurochem. 69 (1997) 2336-2344.
23. A. Reifman, R.J. Wyatt, Lithium: a brake in the rising cost of mental illness, Arch. Gen. Psychiatry 37 (1980) 385-388.
24. M. Schou, Clinical aspects of lithium in psychiatry, in: N.J. Birch (Ed.), Lithium and the Cell, Academic Press, London, 1991, pp. 1-6.
25. V. Stambolic, Ruel, R. Laurent, J.R. Woodgett, Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells, Curr. Biol. 6 (1996) 1664-1668.
26. M.T. Unlap, R.S. Jope, Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells, Neuropsychopharmacology 17 (1) (1997) 12-17.
27. A.J. Whitmarsh, R.J. Davis, Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways, J. Mol. Med. 74 (1996) 589-607.
28. M.B. Williams, R.S. Jope, Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium, Psychopharmacology (Berl.) 122 (4) (1995) 363-368.